Pharma Industry News
August 7th, 2009
The US FDA has advised healthcare practitioners and consumers of current safety information with regard to body building and increase muscle mass products, these products are commonly described as a substitute for anabolic steroids (used to increase muscle mass and strength), available both online and in retail establishments.
August 7th, 2009
The FDA’s laboratory analysis discovered sulfoaildenafil, an analog of sildenafil. Sildenafil is a key ingredient in the FDA-approved drug for erectile dysfunction, which makes Steam an unsanctioned drug.
August 7th, 2009
Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine. Currently, Baxter is discussing distribution options with national health authorities, so long as they receive appropriate permission. Baxter implemented their proprietary Vero cell production technology when developing CELVAPAN.
August 7th, 2009
The US FDA requires TNF blockers to include firm detailed warnings in the prescribing information. The warnings, which also involves an up to date box warning, spotlights the increase chance of cancer in children and adolescents who first obtain the drug to treat juvenile rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and other inflammatory diseases.
August 7th, 2009
The US FDA cautions consumers of the harmful effects Clarcon skin products are having on the skin. They urge consumers to cease all usage of Clarcon Biological Chemistry Laboratory skin sanitizer or protectants, because of hazardous bacteria.
August 7th, 2009
Biopharmaceutical company Insmed Inc. has publicized that effective immediately, they will halt new patient distribution of Iplex. They feel it is in the existing patients best interest to maintain supplies at this time for their treatment only. As a result, at this time, Insmed will not instigate further clinical trials of Iplex.
August 7th, 2009
Recently, the US FDA has approved a once-daily tablet to treat adult Type 2 Diabetes. Along with diet and exercise, Onglyza will assist to manage high blood sugar levels.
August 7th, 2009
The US FDA has recently approved Invega Sustenna extended-release injectable suspension for acute and maintenance therapy of adult schizophrenia. Invega Sustenna is the first US approved once a month injectable, long-acting, atypical antipsychotic.
August 7th, 2009
US researchers report confidence in Nanoparticles ability to carry cancer-killing radioisotopes directly to tumors
August 7th, 2009
Recently, Ranbaxy Pharmaceuticals Inc. announced their voluntary recall of all Nitrofurantoin Capsules lot (USP 100 mg capsules), that currently exist on the U.S. marke
